MarketPeel
Insider Trading Intelligence
LM

Lynne Fahey Mcgrath

ALZN
DIRECTOR · ALZAMEND NEURO, INC. · CIK 0001866270
FILING MIX · LIFETIME58%/42%
BUYS
7
SELLS
5
TOTAL VALUE
$65.1K
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
25
AVG SELL PX
$1.21
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Lynne Fahey Mcgrath, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+2.25%+0.99%+1.26%-1.83%
14d4+50.00%-1.90%-0.82%-1.08%-1.13%
30d4+75.00%-6.94%-3.43%-3.50%-15.04%
60d4+75.00%-9.12%-2.27%-6.85%-12.85%
90d4+50.00%+3.50%-3.71%+7.21%-3.67%
180d4+50.00%-31.15%-4.61%-26.53%-25.67%
1y4(1 pending)+33.33%-70.87%+3.86%-74.74%-52.56%
2y4(1 pending)+33.33%-95.77%+28.18%-123.95%-112.82%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALZN · 25 shares · as of Oct 23, 2025
075,000150,000225,000300,0002022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 7 buys / 5 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALZN
ALZAMEND NEURO, INC.
SALE
30$2.29$6925Oct 23, 2025Oct 24, 2025View →
ALZN
ALZAMEND NEURO, INC.
PURCHASE
10,000$0.44$4.3K10,000Mar 22, 2023Mar 23, 2023View →
ALZN
ALZAMEND NEURO, INC.
SALE
25,000$1.21$30.3K75,000Mar 28, 2022Apr 8, 2022View →
ALZN
ALZAMEND NEURO, INC.
PURCHASE
25,000$1.21$30.3K75,000Mar 28, 2022Apr 6, 2022View →
ALZN
ALZAMEND NEURO, INC.
SALE
50,0000Mar 15, 2022Mar 15, 2022View →
ALZN
ALZAMEND NEURO, INC.
PURCHASE
50,000100,000Mar 15, 2022Mar 15, 2022View →
ALZN
ALZAMEND NEURO, INC.
PURCHASE
47,22250,000Oct 15, 2021Oct 18, 2021View →
ALZN
ALZAMEND NEURO, INC.
SALE
47,22250,000Oct 15, 2021Oct 18, 2021View →
ALZN
ALZAMEND NEURO, INC.
PURCHASE
2,7782,778Sep 13, 2021Sep 15, 2021View →
ALZN
ALZAMEND NEURO, INC.
SALE
2,77897,222Sep 13, 2021Sep 15, 2021View →
ALZN
ALZAMEND NEURO, INC.
PURCHASEGRANT
Stock grant
300,000300,000Jun 15, 2021Jul 16, 2021View →
ALZN
ALZAMEND NEURO, INC.
PURCHASEGRANT
Stock grant
100,000100,000Jun 15, 2021Jul 16, 2021View →
Other insiders · ALZN
Loading peer insiders…
About this filer
CIK 0001866270
ROLE
Director
PRIMARY
ALZN
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001866270DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback